Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Operating Leases (2019 - 2025)

CorMedix's Operating Leases history spans 7 years, with the latest figure at $2.3 million for Q4 2025.

  • For Q4 2025, Operating Leases rose 545.56% year-over-year to $2.3 million; the TTM value through Dec 2025 reached $2.3 million, up 545.56%, while the annual FY2025 figure was $2.3 million, 545.56% up from the prior year.
  • Operating Leases for Q4 2025 was $2.3 million at CorMedix, down from $2.4 million in the prior quarter.
  • Across five years, Operating Leases topped out at $2.4 million in Q3 2025 and bottomed at $258000.0 in Q2 2025.
  • The 5-year median for Operating Leases is $668000.0 (2022), against an average of $826875.9.
  • The largest annual shift saw Operating Leases soared 47205.04% in 2021 before it plummeted 56.57% in 2025.
  • A 5-year view of Operating Leases shows it stood at $802433.0 in 2021, then decreased by 16.75% to $668000.0 in 2022, then fell by 16.7% to $556416.0 in 2023, then tumbled by 37.28% to $349000.0 in 2024, then skyrocketed by 545.56% to $2.3 million in 2025.
  • Per Business Quant, the three most recent readings for CRMD's Operating Leases are $2.3 million (Q4 2025), $2.4 million (Q3 2025), and $258000.0 (Q2 2025).